Ligand Pharmaceuticals Incorporated (LGND) vs RadNet, Inc. (RDNT)
A side-by-side comparison of Ligand Pharmaceuticals Incorporated and RadNet, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LGND
Ligand Pharmaceuticals Incorporated
$296.94HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RDNT
RadNet, Inc.
$70.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — LGND vs RDNT
growth of $100 · dividends reinvested · last 10yLGND +389.0% (+17.2%/yr)RDNT +844.7% (+25.2%/yr)RDNT compounded faster over this window
LGND RDNT
LGND vs RDNT: by the numbers
- •LGND is the larger company ($5.95B vs $5.53B market cap).
- •LGND is profitable (67.88% net margin) while RDNT runs a net loss (-0.93%).
- •RDNT grew revenue faster over the past five years (12.68% vs 2.92% CAGR).
Metrics side by side
Valuation
| Metric | LGND | RDNT |
|---|---|---|
| P/E ratio | 31.76 | N/A |
| Forward P/E | 31.91 | 136.65 |
| P/S ratio | 20.48 | 2.44 |
| P/B ratio | 6.15 | 5.04 |
| EV / EBITDA | 45.02 | 21.70 |
| FCF yield | 2.21% | N/A |
Profitability
| Metric | LGND | RDNT |
|---|---|---|
| Gross margin | 98.58% | 9.70% |
| Operating margin | 17.61% | 4.00% |
| Net margin | 67.88% | -0.93% |
| ROE | 20.38% | -1.93% |
| ROIC | 3.91% | 1.41% |
Growth (annualized)
| Metric | LGND | RDNT |
|---|---|---|
| Revenue CAGR (5Y) | 2.92% | 12.68% |
| FCF CAGR (5Y) | -0.49% | N/A |
| Total return CAGR (5Y) | 30.72% | 19.72% |
Frequently asked
- Which has grown faster, LGND or RDNT?
- Over the past five years, RDNT grew revenue faster — LGND at a 2.92% CAGR versus RDNT at 12.68%.
- Is LGND or RDNT more profitable?
- LGND runs the higher net margin — LGND at 67.88% versus RDNT at -0.93%.
- How have LGND and RDNT total returns compared?
- Over the past 10 years, LGND delivered 17.12% and RDNT delivered 25.20% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Ligand Pharmaceuticals P/E ratioLigand Pharmaceuticals ROERadNet ROELigand Pharmaceuticals operating marginRadNet operating marginLigand Pharmaceuticals revenue growthRadNet revenue growthLigand Pharmaceuticals free cash flowRadNet free cash flow
Ligand Pharmaceuticals & RadNet appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.